About 10% of people hospitalized with sickle cell on Long Island between 2009 and 2022 faced a "major risk of mortality," ...

Learn about the groundbreaking gene therapy for sickle cell disease at Manning Family Children's Hospital in Louisiana, ...

Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...

Novel conditioning regimen improves survival and engraftment in sickle cell transplant patients with low graft versus host ...

A sweeping look at more than a decade of New York hospital data has handed Long Island a dubious distinction: the region ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Most patients living with sickle cell disease who went to the emergency ...

Sickle cell disease (SCD) is the most common inherited blood disorder in the United States. Approximately 10% of people with ...

Q1 2026 Management View Brian Goff (CEO & Director) said the company is “off to a strong start entering another catalyst-rich year,” highlighting $20.7 million in net revenues and “138% growth ...

Etavopivat showed a 27% reduction in vaso-occlusive crisis events and ~4-month delay to first vaso-occlusive crisis event on ...

The 33rd annual walkathon for the Northeast Louisiana Sickle Cell anemia Foundation is scheduled for this Saturday at the ...

Agios (AGIO) downgraded to Hold as Novo Nordisk rivalry and FDA/REMS risks hit sickle cell & thalassemia; pipeline and cash ...